ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 900 filers reported holding ISHARES TR in Q4 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,789,948 | -0.4% | 20,326 | -0.4% | 0.01% | -8.3% |
Q1 2024 | $2,800,935 | +0.9% | 20,412 | -0.1% | 0.01% | 0.0% |
Q4 2023 | $2,777,050 | +10.5% | 20,442 | -0.5% | 0.01% | 0.0% |
Q3 2023 | $2,512,084 | -3.6% | 20,542 | +0.0% | 0.01% | 0.0% |
Q2 2023 | $2,606,743 | -2.7% | 20,532 | -1.0% | 0.01% | -7.7% |
Q1 2023 | $2,679,038 | -3.5% | 20,742 | -1.9% | 0.01% | -7.1% |
Q4 2022 | $2,776,786 | +10.4% | 21,150 | -1.6% | 0.01% | +7.7% |
Q3 2022 | $2,515,000 | +0.3% | 21,502 | +0.8% | 0.01% | +8.3% |
Q2 2022 | $2,508,000 | -9.9% | 21,322 | -0.3% | 0.01% | 0.0% |
Q1 2022 | $2,785,000 | -18.6% | 21,376 | -4.6% | 0.01% | -14.3% |
Q4 2021 | $3,421,000 | -17.5% | 22,414 | -12.6% | 0.01% | -22.2% |
Q3 2021 | $4,149,000 | -0.4% | 25,659 | +0.8% | 0.02% | 0.0% |
Q2 2021 | $4,167,000 | -46.0% | 25,464 | -50.3% | 0.02% | 0.0% |
Q1 2021 | $7,710,000 | +97.5% | 51,212 | +98.7% | 0.02% | -5.3% |
Q4 2020 | $3,904,000 | +11.7% | 25,769 | -0.1% | 0.02% | 0.0% |
Q3 2020 | $3,494,000 | -6.4% | 25,806 | -5.5% | 0.02% | -13.6% |
Q2 2020 | $3,732,000 | +25.7% | 27,306 | -0.9% | 0.02% | +10.0% |
Q1 2020 | $2,968,000 | -11.7% | 27,551 | -1.3% | 0.02% | +11.1% |
Q4 2019 | $3,363,000 | +17.5% | 27,910 | -3.0% | 0.02% | +12.5% |
Q3 2019 | $2,862,000 | -10.2% | 28,759 | -1.6% | 0.02% | -15.8% |
Q2 2019 | $3,187,000 | -1.8% | 29,216 | +0.7% | 0.02% | 0.0% |
Q1 2019 | $3,245,000 | +13.7% | 29,021 | -2.0% | 0.02% | 0.0% |
Q4 2018 | $2,855,000 | -30.8% | 29,603 | -12.5% | 0.02% | -17.4% |
Q3 2018 | $4,124,000 | +5.4% | 33,823 | -5.1% | 0.02% | 0.0% |
Q2 2018 | $3,914,000 | +1.8% | 35,637 | -1.0% | 0.02% | 0.0% |
Q1 2018 | $3,844,000 | -6.8% | 36,012 | -6.8% | 0.02% | -4.2% |
Q4 2017 | $4,124,000 | -7.2% | 38,622 | +190.0% | 0.02% | -7.7% |
Q3 2017 | $4,442,000 | +6.9% | 13,317 | -0.6% | 0.03% | +4.0% |
Q2 2017 | $4,155,000 | +5.0% | 13,400 | -0.7% | 0.02% | +4.2% |
Q1 2017 | $3,959,000 | +7.5% | 13,498 | -2.8% | 0.02% | +4.3% |
Q4 2016 | $3,684,000 | -15.1% | 13,881 | -7.4% | 0.02% | -14.8% |
Q3 2016 | $4,340,000 | +25.0% | 14,995 | +11.1% | 0.03% | +17.4% |
Q2 2016 | $3,473,000 | -0.9% | 13,496 | +0.4% | 0.02% | 0.0% |
Q1 2016 | $3,506,000 | -32.9% | 13,441 | -12.9% | 0.02% | -34.3% |
Q4 2015 | $5,222,000 | -2.2% | 15,434 | -12.3% | 0.04% | -7.9% |
Q3 2015 | $5,338,000 | -21.6% | 17,597 | -4.6% | 0.04% | -15.6% |
Q2 2015 | $6,807,000 | +1.1% | 18,449 | -5.9% | 0.04% | +2.3% |
Q1 2015 | $6,735,000 | +12.6% | 19,610 | -0.5% | 0.04% | +12.8% |
Q4 2014 | $5,981,000 | +9.2% | 19,717 | -1.5% | 0.04% | +2.6% |
Q3 2014 | $5,476,000 | +4.5% | 20,014 | -1.8% | 0.04% | +8.6% |
Q2 2014 | $5,240,000 | +1.9% | 20,388 | -6.2% | 0.04% | -12.5% |
Q1 2014 | $5,140,000 | +1.0% | 21,744 | -3.0% | 0.04% | +21.2% |
Q4 2013 | $5,091,000 | +4.9% | 22,421 | -3.2% | 0.03% | 0.0% |
Q3 2013 | $4,854,000 | +17.6% | 23,159 | -2.5% | 0.03% | +120.0% |
Q2 2013 | $4,129,000 | +7.0% | 23,749 | -1.6% | 0.02% | +7.1% |
Q1 2013 | $3,860,000 | +17.8% | 24,134 | +1.1% | 0.01% | +7.7% |
Q4 2012 | $3,276,000 | – | 23,875 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |